Page last updated: 2024-11-03

rabeprazole and Gastric Diseases

rabeprazole has been researched along with Gastric Diseases in 6 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Jung, YS2
Kim, S2
Kim, HY2
Noh, SJ2
Park, JH2
Sohn, CI2
Park, CH2
Kawasaki, K1
Kurahara, K1
Oshiro, Y1
Ohtsu, K1
Nakamura, S1
Fuchigami, T1
Matsumoto, T1
Hwang, JJ1
Lee, DH1
Lee, AR1
Yoon, H1
Shin, CM1
Park, YS1
Kim, N1
Wu, DC1
Kuo, CH1
Tsay, FW1
Hsu, WH1
Chen, A1
Hsu, PI1
Osipenko, MF1
Konstantinov, VI1
Moiseenko, EE1
Bikbulatova, EA1
Kawai, T1
Kawakami, K1
Mikinori, K1
Takei, K1
Itoi, T1
Moriyasu, F1
Takagi, Y1
Aoki, T1
Watanebe, K1
Matsumoto, Y1
Rimbara, E1
Noguchi, N1
Sasatsu, M1

Trials

3 trials available for rabeprazole and Gastric Diseases

ArticleYear
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    World journal of gastroenterology, 2015, Apr-28, Volume: 21, Issue:16

    Topics: Aged; Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Administration Schedule; Dru

2015
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection.
    Medicine, 2016, Volume: 95, Issue:11

    Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Dexlansoprazole; Drug Resistance, Bacterial; Dru

2016
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.
    Hepato-gastroenterology, 2007, Volume: 54, Issue:74

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarb

2007

Other Studies

3 other studies available for rabeprazole and Gastric Diseases

ArticleYear
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
    Gut and liver, 2023, 09-15, Volume: 17, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infectio

2023
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
    Gut and liver, 2023, 09-15, Volume: 17, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infectio

2023
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
    Gut and liver, 2023, 09-15, Volume: 17, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infectio

2023
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
    Gut and liver, 2023, 09-15, Volume: 17, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infectio

2023
Gastrointestinal: Idiopathic granulomatous gastritis observed by magnifying narrow-band imaging endoscopy.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combinati

2017
[The first results of the program Effective Eradication in Novosibirsk].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2008, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Cities; Helicobacter Infections; Helicob

2008
chemdatabank.com